Preprint · OA
via OpenAlex
A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases
Jialiang Yang, Bin Zhang, Sander M. Houten, Eric E. Schadt, Jun Zhu, Yousin Suh, Zhidong Tu
bioRxiv (Cold Spring Harbor Laboratory) · 2018 · ▲ 1 citations
Abstract
Abstract A key goal of geroscience research is to discover effective interventions to extend human healthspan(definition), the years of healthy life. Currently, majority of the geroprotectors are found by testing compounds in model organisms; whether these compounds will be effective in humans is largely unknown. Here we present a novel strategy called ANDRU ( a ging n etwork based dru g discovery) to help the discovery of human geroprotectors. Instead of relying on model organisms, this approach is driven by human genomic and pharmacogenomic data. It first identifies human aging subnetworks that putatively function at the interface between aging and age-related diseases; it then screens for pharmacological or genetic interventions that may “reverse” the age-associated transcriptional changes seen in these subnetworks. We applied ANDRU to human adipose and artery tissues. In adipose tissue, PTPN1 , a target for diabetes treatment and APOE , a known genetic factor for human longevity and diseases like Alzheimer’s disease, were ranked at the top. For small molecules, conjugated linoleic acid and metformin, a drug commonly used to treat type 2 diabetes, were ranked among the top compounds. In artery tissue, N-methyl-D-aspartate antagonists and curcumin were ranked at the top. In summary, ANDRU represents a promising human data-driven strategy that may speed up the discovery of interventions to extend human healthspan.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/326264
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Yang, J., Zhang, B., Houten, S.M., Schadt, E.E., Zhu, J., Suh, Y., & Tu, Z. (2018). A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/326264
Vancouver
Yang J, Zhang B, Houten SM, Schadt EE, Zhu J, Suh Y, et al. A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases. bioRxiv (Cold Spring Harbor Laboratory). 2018. doi:10.1101/326264.
BibTeX
@unpublished{jialiang2018Anovel,
title = {A novel approach of human geroprotector discovery by targeting the converging subnetworks of aging and age-related diseases},
author = {Jialiang Yang and Bin Zhang and Sander M. Houten and Eric E. Schadt and Jun Zhu and Yousin Suh and Zhidong Tu},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2018},
doi = {10.1101/326264},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Research Square 2023
Preprint · CC-BY
PICLS with human cells - first high-throughput screening method with human assay identifies novel longevity compounds including 2,5-anhydro-D-mannitol that increase chronological lifespan
Aging Cell 2024
Open access · CC-BY
Causal associations and shared genetic etiology of neurodegenerative diseases with epigenetic aging and human longevity
Aging Cell 2021
Open access · CC-BY
Youthful and age‐related matreotypes predict drugs promoting longevity
International Journal of Molecular Sciences 2021
Open access · CC-BY
Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
Neurochemical Research 2008
Preprint · CC-BY
Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity
Cell Cycle 2008
Open access · OA